Antinuclear Antibody Test Market

An ANA (antinuclear antibody) test looks for antinuclear antibodies in your blood. If the test finds antinuclear antibodies in your blood, it may mean you have an autoimmune disorder. An autoimmune disorder causes your immune system to attack your own cells, tissues, and/or organs by mistake. These disorders can cause serious health problems.

Antibodies are proteins that your immune system makes to fight foreign substances like viruses and bacteria. But an antinuclear antibody attacks your own healthy cells instead. It's called "antinuclear" because it targets the nucleus (center) of the cells.

Antinuclear Antibody Test Market contains market size and forecasts of Antinuclear Antibody (ANA) Test in Global, including the following market information:

Global Antinuclear Antibody (ANA) Test Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antinuclear Antibody (ANA) Test market was valued at 976.9 million in 2021 and is projected to reach US$ 1547.8 million by 2028, at a CAGR of 6.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Reagents & Assay Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antinuclear Antibody (ANA) Test include Abbott, Bio-Rad Laboratories, Inc, ERBA Diagnostics, Inc, Trinity Biotech plc, Thermo Fisher Scientific, Inc, Antibodies, Inc, EUROIMMUN AG, Immuno Concepts and Inova Diagnostics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antinuclear Antibody (ANA) Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antinuclear Antibody (ANA) Test Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antinuclear Antibody (ANA) Test Market Segment Percentages, by Type, 2021 (%)

Reagents & Assay Kits

Systems

Software & Service

Global Antinuclear Antibody (ANA) Test Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antinuclear Antibody (ANA) Test Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinical Laboratories

Physician Office Laboratories

Others

Global Antinuclear Antibody (ANA) Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antinuclear Antibody (ANA) Test Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antinuclear Antibody (ANA) Test revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antinuclear Antibody (ANA) Test revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott

Bio-Rad Laboratories, Inc

ERBA Diagnostics, Inc

Trinity Biotech plc

Thermo Fisher Scientific, Inc

Antibodies, Inc

EUROIMMUN AG

Immuno Concepts

Inova Diagnostics

Zeus Scientific